Daiwa Securities Group Inc. increased its stake in shares of Dentsply International Inc. (NASDAQ:XRAY) by 5.5% during the second quarter, Holdings Channel reports. The fund owned 5,800 shares of the company’s stock after buying an additional 300 shares during the period. Daiwa Securities Group Inc.’s holdings in Dentsply International were worth $360,000 as of its most recent filing with the SEC.
Several other hedge funds and other institutional investors also recently made changes to their positions in XRAY. BlackRock Inc. boosted its position in shares of Dentsply International by 14.1% in the first quarter. BlackRock Inc. now owns 420,856 shares of the company’s stock valued at $25,936,000 after buying an additional 51,877 shares during the last quarter. Franklin Resources Inc. boosted its position in shares of Dentsply International by 0.6% in the first quarter. Franklin Resources Inc. now owns 2,437,080 shares of the company’s stock valued at $150,197,000 after buying an additional 13,914 shares during the last quarter. RMB Capital Management LLC bought a new position in shares of Dentsply International during the first quarter valued at about $2,181,000. Prudential Financial Inc. boosted its position in shares of Dentsply International by 20.0% in the first quarter. Prudential Financial Inc. now owns 292,495 shares of the company’s stock valued at $18,027,000 after buying an additional 48,668 shares during the last quarter. Finally, Stratos Wealth Partners LTD. bought a new position in shares of Dentsply International during the first quarter valued at about $208,000. 94.58% of the stock is currently owned by institutional investors.
Shares of Dentsply International Inc. (NASDAQ:XRAY) traded up 0.56% during mid-day trading on Friday, hitting $59.43. The company’s stock had a trading volume of 1,505,778 shares. The stock’s 50 day moving average price is $60.27 and its 200 day moving average price is $61.45. Dentsply International Inc. has a 52-week low of $51.28 and a 52-week high of $65.83.
Dentsply International (NASDAQ:XRAY) last announced its earnings results on Friday, August 5th. The company reported $0.76 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.70 by $0.06. Dentsply International had a return on equity of 9.18% and a net margin of 11.99%. The firm earned $1.02 billion during the quarter, compared to analyst estimates of $1.03 billion. During the same quarter in the prior year, the company earned $0.73 EPS. The business’s revenue was up 46.4% compared to the same quarter last year. On average, analysts forecast that Dentsply International Inc. will post $2.76 earnings per share for the current fiscal year.
The company also recently announced a dividend, which will be paid on Friday, October 14th. Stockholders of record on Friday, September 30th will be given a $0.0775 dividend. The ex-dividend date of this dividend is Wednesday, September 28th. Dentsply International’s dividend payout ratio is currently 14.49%.
XRAY has been the topic of several research analyst reports. Credit Suisse Group AG reissued a “buy” rating on shares of Dentsply International in a research report on Sunday, June 26th. Piper Jaffray Cos. reissued a “buy” rating on shares of Dentsply International in a research report on Monday, June 27th. Bank of America Corp. initiated coverage on Dentsply International in a research report on Monday, September 12th. They issued a “buy” rating and a $70.00 price objective on the stock. Jefferies Group reissued a “buy” rating on shares of Dentsply International in a research report on Wednesday, August 17th. Finally, Zacks Investment Research cut Dentsply International from a “buy” rating to a “hold” rating in a research report on Monday, August 8th. Six equities research analysts have rated the stock with a hold rating and six have assigned a buy rating to the company. The company has an average rating of “Buy” and an average price target of $66.82.
In related news, SVP Maureen J. Macinnis sold 45,100 shares of the firm’s stock in a transaction that occurred on Thursday, August 25th. The stock was sold at an average price of $60.55, for a total transaction of $2,730,805.00. Following the completion of the transaction, the senior vice president now owns 36,730 shares of the company’s stock, valued at approximately $2,224,001.50. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. Also, SVP Maureen J. Macinnis sold 17,650 shares of the firm’s stock in a transaction that occurred on Tuesday, August 23rd. The shares were sold at an average price of $60.61, for a total value of $1,069,766.50. Following the transaction, the senior vice president now directly owns 19,630 shares of the company’s stock, valued at approximately $1,189,774.30. The disclosure for this sale can be found here. 2.20% of the stock is owned by insiders.
About Dentsply International
DENTSPLY SIRONA Inc, formerly DENTSPLY International Inc, designs, develops, manufactures and markets a range of consumable dental products for the professional dental market. The Company also manufactures and markets consumable medical device products consisting mainly of urological catheters and certain surgical products.
Want to see what other hedge funds are holding XRAY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Dentsply International Inc. (NASDAQ:XRAY).
Receive News & Ratings for Dentsply International Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dentsply International Inc. and related companies with MarketBeat.com's FREE daily email newsletter.